JPH1053576A5 - - Google Patents
Info
- Publication number
- JPH1053576A5 JPH1053576A5 JP1997150558A JP15055897A JPH1053576A5 JP H1053576 A5 JPH1053576 A5 JP H1053576A5 JP 1997150558 A JP1997150558 A JP 1997150558A JP 15055897 A JP15055897 A JP 15055897A JP H1053576 A5 JPH1053576 A5 JP H1053576A5
- Authority
- JP
- Japan
- Prior art keywords
- represented
- following
- wavenumber
- peaks
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15055897A JPH1053576A (ja) | 1996-06-07 | 1997-06-09 | 塩酸ドネペジルの多形結晶およびその製造法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8-146293 | 1996-06-07 | ||
| JP14629396 | 1996-06-07 | ||
| JP15055897A JPH1053576A (ja) | 1996-06-07 | 1997-06-09 | 塩酸ドネペジルの多形結晶およびその製造法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004205012A Division JP2005015486A (ja) | 1996-06-07 | 2004-07-12 | 塩酸ドネペジルの多形結晶およびその製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1053576A JPH1053576A (ja) | 1998-02-24 |
| JPH1053576A5 true JPH1053576A5 (https=) | 2005-06-02 |
Family
ID=26477191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15055897A Withdrawn JPH1053576A (ja) | 1996-06-07 | 1997-06-09 | 塩酸ドネペジルの多形結晶およびその製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1053576A (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6274603B1 (en) * | 1997-09-24 | 2001-08-14 | Mcgill University | Methods for increasing ApoE levels for the treatment of neurodegenerative disease |
| ES2218869T3 (es) * | 1997-12-05 | 2004-11-16 | Eisai Co., Ltd. | Cristales polimorficos de donepezil y un proceso para produccion de dichos cristales. |
| JP2007016052A (ja) * | 1998-03-03 | 2007-01-25 | Eisai R & D Management Co Ltd | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
| JP3987655B2 (ja) * | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
| FR2782082B3 (fr) * | 1998-08-05 | 2000-09-22 | Sanofi Sa | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
| US6617361B2 (en) * | 1999-11-05 | 2003-09-09 | Be Able, Llc | Behavior chemotherapy |
| WO2002026709A1 (en) * | 2000-09-25 | 2002-04-04 | Eisai Co., Ltd. | Process for producing multiform crystal of donepezil hydrochloride |
| WO2003018581A1 (en) * | 2001-08-23 | 2003-03-06 | Sumitomo Pharmaceuticals Co., Ltd. | 1,2-dihydro-2-oxo-1,8-naphthyridine derivative |
| JP4298212B2 (ja) * | 2002-03-29 | 2009-07-15 | 大日本印刷株式会社 | 塩酸エピナスチン高融点型結晶の製造法 |
| IL150509A (en) * | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
| US6943249B2 (en) * | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
| UA83504C2 (en) | 2003-09-04 | 2008-07-25 | Селджин Корпорейшн | Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| WO2006035433A2 (en) * | 2004-09-29 | 2006-04-06 | Chemagis Ltd. | Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride |
| ES2317313T3 (es) * | 2004-10-19 | 2009-04-16 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Composicion farmaceutica solida que comprende clorhidrato de donepezilo. |
| WO2006090263A1 (en) * | 2005-02-28 | 2006-08-31 | Ranbaxy Laboratories Limited | Stable form i donepezil hydrochloride and process for its preparation and use in pharmaceutical compositions |
| EP2540725A1 (de) * | 2006-05-04 | 2013-01-02 | Boehringer Ingelheim International GmbH | Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin |
| ES2415166T3 (es) * | 2007-09-28 | 2013-07-24 | Tianjin Hemay Bio-Tech Co., Ltd. | Polímorfos de sales de Donepezilo, métodos de preparación y usos de los mismos |
| JP7164926B2 (ja) * | 2015-04-22 | 2022-11-02 | 日本ケミファ株式会社 | 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の結晶、その製造方法、及びそれらの利用 |
| CN112939846B (zh) * | 2019-11-26 | 2023-12-26 | 中国科学院上海药物研究所 | 一种乙酰胆碱酯酶抑制剂的晶型及其制备方法和应用 |
-
1997
- 1997-06-09 JP JP15055897A patent/JPH1053576A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH1053576A5 (https=) | ||
| JP2006526031A5 (https=) | ||
| CA2064382A1 (en) | Pharmaceutical compounds | |
| JP2002038048A5 (https=) | ||
| FR2843121B3 (fr) | Agent ignifugeant, procede de preparation et l'utilisation de cet agent | |
| SI1542678T1 (sl) | DERIVATI 1H-1,2,4-TRIAZOL-3-KARBOKSAMIDA KOT LIGANDI RECEPTORJA KANABINOIDA-CB sb 1/sb | |
| JP2004504479A5 (https=) | ||
| IL166427A0 (en) | 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands | |
| JP2005533147A5 (https=) | ||
| JP2009503079A5 (https=) | ||
| JP2003160581A5 (https=) | ||
| EP1392083A3 (en) | Cooking apparatus having heaters | |
| JP2005511612A5 (https=) | ||
| JP2002240244A5 (https=) | ||
| JP2001354766A5 (https=) | ||
| JP2005515754A5 (https=) | ||
| NO20000432D0 (no) | Fremgangsmåte for fremstilling av 1,2-dikloretan ved oksyklorering | |
| JP2004269491A5 (https=) | ||
| JP2003105259A5 (https=) | ||
| JP2005513126A5 (https=) | ||
| NO180189C (no) | Fremgangsmåte for opparbeiding av silisiumrike, uopplöste rester fra utluting av kobberholdige residuer fra organoklorsilansyntese | |
| JP2004517145A5 (https=) | ||
| NO20002763L (no) | FremgangsmÕte for fremstilling av 1,2-dikloretan ved oksyklorering | |
| JPH11320393A5 (https=) | ||
| NO20043925L (no) | Fremgangsmate for fremstilling av 1,2-dikloretan ved direkte klorering |